John P. Brancaccio, CPA - Trovagene

Leadership Team

Working to develop oncology therapeutics to improve cancer care

John P. Brancaccio, CPA | Director

John Brancaccio, a retired CPA, has served as a director of our company since December 2005.

Since April 2004, Mr. Brancaccio has been the Chief Financial Officer of Accelerated Technologies, Inc., an incubator for medical device companies. Mr. Brancaccio served as a director of Callisto Pharmaceuticals, Inc. from April 2004 until its merger with Synergy Pharmaceuticals, Inc. in January 2013 and has been a director of Tamir Biotechnology, Inc. (formerly Alfacell Corporation) since April 2004, as well as a director of Synergy Pharmaceuticals Inc. since July 2008, Rasna Therapeutics, Inc. since August 2016 and ContraVir Pharmaceuticals, Inc. since December 2013. The Board believes that Mr. Brancaccio’s chief financial officer experience provides him with valuable financial and accounting expertise that qualifies him to serve as a director of our company.